Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To investigate whether PF 05212384 in combination with irinotecan is superior to cetuximab in combination with irinotecan in prolonging PFS in patients with KRAS and NRAS wild type mCRC who have progressed following prior treatment with irinotecan, oxaliplatin, and fluoropyrimidine.
Critère d'inclusion
- Colorectal Cancer